49 Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-8,459
Closed -$240K 160
2024
Q1
$240K Sell
8,459
-317
-4% -$9.53K 0.05% 103
2023
Q4
$288K Buy
+8,776
New +$239K 0.07% 84

Other funds holding ARKG

49 Wealth Management's ARKG Position: Q2 2024 in Review

49 Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2024, closing a stake of 8,459 shares — an estimated $240K sold.

49 Wealth Management first reported a position in ARKG in Q4 2023 and held it in 2 quarters. The position peaked at $288K in Q4 2023. 261 funds tracked by Wall St. Rank hold ARKG as of Q2 2024.

  • 49 Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2024 after selling out during the quarter.
  • 49 Wealth Management sold 8,459 ARK Genomic Revolution ETF shares in Q2 2024, an estimated $240K.
  • 49 Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2023 and held it in 2 quarters.
  • 49 Wealth Management's ARK Genomic Revolution ETF position peaked at $288K in Q4 2023.
  • 261 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2024.

Based on 49 Wealth Management's 13F filing for Q2 2024, filed 30 Jul 2024.